These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 304068)

  • 1. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
    Sibbitt WL; Bankhurst AD; Williams RC
    J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenic responsiveness and monocyte-lymphocyte interaction of early and late rosette-forming cell populations of human peripheral blood lymphocytes.
    Taniguchi N; Miyawaki T; Moriya N; Nagaoki T; Kato E
    J Immunol; 1977 Jan; 118(1):193-7. PubMed ID: 299756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
    Braun DP; Penn RD; Flannery AM; Harris JE
    Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin-producing suppressor cells in Hodgkin's disease.
    Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
    N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI; Bostick-Bruton F
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G
    Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
    Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
    J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibody response in cultures of lymphocytes from patients with Hodgkin's lymphoma: role of monocytes].
    Villa ML; Colleoni M; Valenti F; Tondini C; Clerici E
    Boll Ist Sieroter Milan; 1987; 66(3):214-21. PubMed ID: 3325076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effect of adherent mononuclear cells from peripheral blood of patients with Hodgkin's disease on PHA responsiveness.
    Moghe MV; Advani SH; Gangal SG
    Indian J Exp Biol; 1981 Dec; 19(12):1101-6. PubMed ID: 7333645
    [No Abstract]   [Full Text] [Related]  

  • 12. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adherent cells in immune responses to phytohemagglutinin and concanavalin A.
    Arala-Chaves MP; Hope L; Korn JH; Fudenberg H
    Eur J Immunol; 1978 Feb; 8(2):77-81. PubMed ID: 306923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
    Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
    Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine lymphocyte subpopulations.
    Atkinson K; Deeg HJ; Storb R; Weiden PL; Gerhard-Miller L; Torok-Storb BJ; Seigneuret M; Thomas ED
    Exp Hematol; 1980 Aug; 8(7):821-9. PubMed ID: 16398012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
    Utsinger PD; Yount WJ
    J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.